SCHEMBL5234548

SCHEMBL5234548

O=C(NCc1ccc(Cl)cc1)Oc1cc(-c2ccncc2)n[nH]c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.49
GSK3B P49841 2/20 0.48
ROCK2 O75116 3/20 0.46
ROCK1 Q13464 1/20 0.46
TP53 P04637 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
GLA P06280 1/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
GRK2 P25098 2/20 0.42
CYP3A4 P08684 2/20 0.42
CASP1 P29466 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
EPHX1 P07099 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5243973 0.90 TSHR (0.48) MAPTGSK3BROCK2ROCK1KDM4E
SCHEMBL5229171 0.89 GSK3B (0.42) MAPTGSK3BROCK2ALDH1A1MAPK1
SCHEMBL5229836 0.89 GSK3B (0.52) MAPTGSK3BTP53
SCHEMBL5229174 0.88 GSK3B (0.43) GSK3BROCK2MAPK1GRK2SMN1; SMN2
SCHEMBL5231874 0.87 CASP1 (0.54) GSK3BROCK2ROCK1KDM4EALDH1A1
SCHEMBL5243212 0.85 GSK3B (0.45) MAPTGSK3BTP53LMNAHPGD
SCHEMBL5235894 0.85 GSK3B (0.57) GSK3BROCK2ROCK1MAPK1CASP1
SCHEMBL5227844 0.85 GSK3B (0.57) MAPTGSK3BTP53
SCHEMBL5228636 0.85 GSK3B (0.48) MAPTGSK3BTP53ALDH1A1LMNA
SCHEMBL5232027 0.84 EPHX1 (0.51) MAPTGSK3BROCK2ROCK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611121-B1 PYRIDAZINONE DERIVATIVES AS CDK2-INHIBITORS AVENTIS PHARMA SA (FR) 2007-08-08 EP claimed
EP-1581505-B1 PYRIDAZINONE DERIVATIVES AS GSK-3BETA INHIBITORS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-08-01 EP claimed